Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Status:
Active, not recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The Symplicity HTN-3 study is a, multi-center, prospective, single-blind, randomized,
controlled study of the safety and effectiveness of renal denervation in subjects with
uncontrolled hypertension. Bilateral renal denervation will be performed using the
Symplicity Catheter - a percutaneous system that delivers radiofrequency (RF)energy through
the luminal surface of the renal artery.